Link4Health: A Combination Strategy for Linkage and Retention, Swaziland

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2201 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-08-31

Study Completion Date

2021-10-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite increased HIV (Human Immunodeficiency Virus) infection testing in Africa, many patients never enroll in subsequent HIV care after testing or remain in care after an initial enrollment. This study's aim is to improve linkage to HIV care and retention in HIV care through the use of feasible, evidence-based, and practical interventions. The study takes place in Swaziland, the country with the highest HIV prevalence (24%) in sub-Saharan Africa. The study will randomize groups of HIV testing sites and affiliated clinics to either standard of care or a combined intervention strategy (CIS) which consists of point-of care CD4 (cluster differentiation 4 (CD4)) testing at time of HIV testing, fast-track HIV medications for those who are eligible for treatment,mobile phone appointment reminders, care bags filled with health prevention materials, and financial incentives. The study outcomes are linkage to and retention in care as well as cost effectiveness, feasibility of interventions, and patient acceptability of interventions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Linkage of patients from HIV testing to HIV care programs and their retention once enrolled in care are essential to HIV program effectiveness in terms of prevention of HIV;related morbidity and mortality and prevention of HIV transmission. Linkage and retention rates in HIV programs in sub-Saharan Africa (SSA) are suboptimal, with less than half of patients who test positive successfully linking and remaining in care at 1 year. This study is a two-arm cluster site;randomized trial to compare the effectiveness of a novel combination package of evidence;based interventions, the combination intervention strategy (CIS), compared to standard of care (SOC) on linkage and retention of HIV;positive patients from point of testing to retention in care. CIS will include 1) point of care CD4+ count assays at HIV testing sites; 2) accelerated antiretroviral therapy (ART) initiation for eligible patients; 3) provision of a basic care and prevention package (BCPP); 4) short message service (SMS) reminders for clinic appointments; and 5) financial incentives for linkage and retention. The primary aim is to evaluate the effectiveness of CIS as compared to SOC on the combined outcome of rapid linkage to HIV care within 1 month and retention in care at 12 months among adults testing positive for HIV. Secondary aims include evaluation of the effectiveness of CIS compared to SOC on each of linkage to HIV; retention in care; time to ART initiation; HIV disease progression and mortality; patient acceptability; association between baseline characteristics and outcomes, and comparison of cost effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV (Human Immunodeficiency Virus)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of Care

Participants will be managed per standard of care following prevailing Swaziland Ministry of Health guidelines.

Group Type NO_INTERVENTION

No interventions assigned to this group

Combined Intervention Strategy

Point-of-care (POC) CD4+ (cluster of differentiation 4) Count Accelerated ART initiation for ART eligible participants Basic care and prevention package Cellular Appointment Reminders and Follow-Up Financial Incentives

Group Type EXPERIMENTAL

POC (point-of-care) CD4+ (cluster of differentiation 4) Count

Intervention Type PROCEDURE

Each HIV testing and counseling (HTC) site will be equipped with POC CD4+ testing using PIMA™ Analyser (Inverness), test strips, and reagents. Study staff will obtain 25 microliters of blood via finger prick and process the POC (point-of-care) CD4+ (cluster of differentiation 4) Count' test immediately following the baseline interview. Test results will be recorded on study forms including a referral form that has multiple copies, one copy to be given to the participant, the second sent to the affiliated HIV (Human immunodeficiency virus)care clinic in the study unit, and the third kept by study staff in a locked cabinet with other confidential material. All participants, regardless of the CD4+ result, will be encouraged to enroll in HIV care as soon as they can.

Accelerated ART (antiretroviral therapy) Initiation

Intervention Type PROCEDURE

Accelerated ART initiation for patients with POC CD4+ \< 350 cells/uL (micro-liter) within 1 week from testing.

2 counseling sessions (one at time of HTC and other at first HIV clinic visit), and collection of blood for other baseline lab tests, but initiation prior to return of results for patients who do not meet criteria for waiting

Basic Care and Prevention Package

Intervention Type BEHAVIORAL

Basic care and prevention package (BCPP) provided approximately every three months that includes: condoms; soap, pill box and pictorial education about use of materials and HIV, such as family testing tools and information. Information on BCPP contents and review the educational materials will be provided. An example of educational materials is a family-testing tool to encourage the participant to have all family members tested for HIV. All BCPP items will be replenished every 3 months for all participants, regardless of ART status, beginning at linkage to HIV care.

Cellular Appointment Reminders and Follow-Up

Intervention Type BEHAVIORAL

SMS (short messaging service) appointment reminders for follow-up appointments.

Telephone call within 7 days of missed appointment for all patients.

Financial Incentive

Intervention Type OTHER

Participants will receive a series of financial incentives to support linkage into care within 1 month and retention in care at 6 months and 12 months after testing HIV positive. The value of the financial incentive (FI) will be 80 Swaziland Rand, calculated based on the associated financial costs of traveling to clinic. These incentives will be distributed by through mobile airtime. Participants without mobile phones will be given an alternative incentive of equal value, such as a store voucher.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

POC (point-of-care) CD4+ (cluster of differentiation 4) Count

Each HIV testing and counseling (HTC) site will be equipped with POC CD4+ testing using PIMA™ Analyser (Inverness), test strips, and reagents. Study staff will obtain 25 microliters of blood via finger prick and process the POC (point-of-care) CD4+ (cluster of differentiation 4) Count' test immediately following the baseline interview. Test results will be recorded on study forms including a referral form that has multiple copies, one copy to be given to the participant, the second sent to the affiliated HIV (Human immunodeficiency virus)care clinic in the study unit, and the third kept by study staff in a locked cabinet with other confidential material. All participants, regardless of the CD4+ result, will be encouraged to enroll in HIV care as soon as they can.

Intervention Type PROCEDURE

Accelerated ART (antiretroviral therapy) Initiation

Accelerated ART initiation for patients with POC CD4+ \< 350 cells/uL (micro-liter) within 1 week from testing.

2 counseling sessions (one at time of HTC and other at first HIV clinic visit), and collection of blood for other baseline lab tests, but initiation prior to return of results for patients who do not meet criteria for waiting

Intervention Type PROCEDURE

Basic Care and Prevention Package

Basic care and prevention package (BCPP) provided approximately every three months that includes: condoms; soap, pill box and pictorial education about use of materials and HIV, such as family testing tools and information. Information on BCPP contents and review the educational materials will be provided. An example of educational materials is a family-testing tool to encourage the participant to have all family members tested for HIV. All BCPP items will be replenished every 3 months for all participants, regardless of ART status, beginning at linkage to HIV care.

Intervention Type BEHAVIORAL

Cellular Appointment Reminders and Follow-Up

SMS (short messaging service) appointment reminders for follow-up appointments.

Telephone call within 7 days of missed appointment for all patients.

Intervention Type BEHAVIORAL

Financial Incentive

Participants will receive a series of financial incentives to support linkage into care within 1 month and retention in care at 6 months and 12 months after testing HIV positive. The value of the financial incentive (FI) will be 80 Swaziland Rand, calculated based on the associated financial costs of traveling to clinic. These incentives will be distributed by through mobile airtime. Participants without mobile phones will be given an alternative incentive of equal value, such as a store voucher.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PIMA BCPP FI (Financial Incentive)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Testing HIV-positive at an HTC (HIV testing and counseling) site within a SU (study unit)
* Willing to be referred to an HIV care clinic associated with the SU
* Willing to provide locator information
* Willing to adhere to study procedures, including a baseline interview, home-based interviews at 1 and 12 months after study enrollment; home-based CD4+ count assessment 12 months after enrollment, and abstraction of data from their medical records.
* Able to provide informed consent

Exclusion Criteria

* Planning on leaving the community where they currently reside in the next 12 months for a period greater than 6 months
* Enrolled in HIV (Human immunodeficiency virus) care in the past 6 months at any HIV care clinic
* Currently on ART (antiretroviral therapy)
* Initiated ART (for any duration) in the past 6 months at any HIV care clinic
* Does not speak or understand English or si-Swati
* Reports being currently pregnant at time of study enrollment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

McNairy ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, Burke S, Mazibuko S, Okello V, Ehrenkranz P, Sahabo R, El-Sadr WM. Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial. PLoS Med. 2017 Nov 7;14(11):e1002420. doi: 10.1371/journal.pmed.1002420. eCollection 2017 Nov.

Reference Type DERIVED

PMID: 29112963 (View on PubMed)

McNairy ML, Gachuhi AB, Lamb MR, Nuwagaba-Biribonwoha H, Burke S, Ehrenkranz P, Mazibuko S, Sahabo R, Philip NM, Okello V, El-Sadr WM. The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial. Implement Sci. 2015 Jul 19;10:101. doi: 10.1186/s13012-015-0291-4.

Reference Type DERIVED

PMID: 26189154 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R01AI100059-02

Identifier Type: NIH

Identifier Source: secondary_id

View Link

AAAL2708

Identifier Type: -

Identifier Source: org_study_id

Link4Health: A Combination Strategy for Linkage and Retention, Swaziland

Study Results

Basic Information

Brief Summary

Detailed Description

Conditions

Study Design

Study Groups

Standard of Care

Combined Intervention Strategy

POC (point-of-care) CD4+ (cluster of differentiation 4) Count

Accelerated ART (antiretroviral therapy) Initiation

Basic Care and Prevention Package

Cellular Appointment Reminders and Follow-Up

Financial Incentive

Interventions

POC (point-of-care) CD4+ (cluster of differentiation 4) Count

Accelerated ART (antiretroviral therapy) Initiation

Basic Care and Prevention Package

Cellular Appointment Reminders and Follow-Up

Financial Incentive

Other Intervention Names

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sponsors

National Institutes of Health (NIH)

National Institute of Allergy and Infectious Diseases (NIAID)

Centers for Disease Control and Prevention

New York University

Columbia University

Responsible Party

Principal Investigators

Wafaa El-Sadr, MD MPH

Charles Azih, MD MPH

Scott Braithwaite, MD MSc

Batya Elul, PhD MD

Peter Ehrenkranz, MD MPH

Matthew Lamb, PhD MPH

Margaret McNairy, MD MSc

Phumzile Mndzebele

Ruben Sahabao, MD

Locations

Bhalekane Clinic

Dvokolwako

Good Shepherd Hospital

Hlatikhulu Hospital

Horo

Kamfishane

Lamvelase

Luyengo Clinic

Mangweni Clinic

Mankayane Hospital

Mashobneni Clinic

Mbabane Government Hospital

Mkhuzweni Health Center

Motshane

Mpolenjeni Clinic

Nhlangano Health Center

Piggs Peak

Raleigh Fitkin Memorial Hospital

Siphofaneni Clinc

Sithobeloa Rural Health Center

Countries

References

Other Identifiers

5R01AI100059-02

AAAL2708